FDA-approved transdermal delivery systems for testosterone include patches, gels, and buccal tablets. A more convenient method to deliver testosterone through the skin is needed, however, as problems ...

Transdermal exogenous testosterone improves libido in postmenopausal women receiving estrogen therapy. Davis et al. have now demonstrated that 300 µg of testosterone a day, administered via skin ...

Hypogonadal men found to have greater clinical improvement with transdermal delivery. TORONTO—Smooth and prolonged release of testosterone by transdermal delivery (Testopatch) translates into greater ...

ARSYNL Rx Launches Exclusive HypoSpray® Transdermal Testosterone Option, Marking a New Era in Hormone Support Dover, United States – February 5, 2026 / ARSYNL Rx / ARSYNL Rx, a leader in ...

Cleveland, Ohio - August 14, 2007 – Novel research published in the current issue of The Journal of Sexual Medicine supports the claim that women with hypoactive sexual desire disorder or HSDD ...

(HealthDay News) – Evidence suggests that transdermal testosterone patches may relieve symptoms of hypoactive sexual desire disorder (HSDD) in postmenopausal women, according to a review published ...

Phase III double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea during pelvic radiation therapy: Results of North Central Cancer Treatment Group protocol N00CA ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eight years ago, I wrote about a startup trying to deliver cancer ...